Longeveron INC S-1 registration statements

Longeveron Inc. has filed a registration statement for the resale of up to 30,865,385 shares of its Class A common stock by certain selling stockholders.

Longeveron Inc. filed an S-1/A registration statement to offer up to 3.85 million Class A common shares and 9.62 million Class A common warrants, aiming to raise approximately $5.2 million to fund its clinical development programs amidst a 'going concern' warning.

Longeveron Inc. files an S-1 registration statement to raise up to $5.2 million through a public offering of common stock and warrants to fund ongoing clinical trials for its lead product, laromestrocel.

Longeveron has filed a registration statement for the resale of up to 2,565,392 shares of Class A common stock by selling stockholders, primarily related to recent warrant exercises and offerings.

Longeveron is registering the resale of up to 3,563,764 shares of its Class A common stock by selling stockholders after a recent warrant inducement transaction.

Longeveron has filed an amendment to its Form S-1 registration statement to register the resale of up to 4,967,470 shares of Class A common stock by selling stockholders.

Longeveron has filed a registration statement for the resale of up to 4,967,470 shares of Class A common stock by selling stockholders, primarily stemming from recent warrant exercises.

Longeveron Inc. has filed an amendment to its Form S-1 registration statement to allow selling stockholders to resell up to 145,020 shares of Class A common stock.

Longeveron Inc. is offering up to 2,461,538 shares of Class A common stock along with warrants to fund clinical trials and general corporate purposes.

Longeveron Inc. is offering up to 2,461,538 shares of Class A Common Stock along with warrants in a public offering to fund clinical trials and general corporate purposes.

Longeveron Inc. plans a public offering of Class A common stock and warrants, alongside a 1-for-10 reverse stock split to regain Nasdaq compliance.

Longeveron is registering the resale of up to 1,450,172 shares of its Class A Common Stock by selling stockholders, issuable upon the exercise of certain warrants.